The Food and Drug Administration granted a final approval to pemfexy, a branded alternative chemotherapy injection for patients with advanced or metastatic nonsquamous non-small cell lung cancer, potentially offering them a cheaper treatment option in the future.
The Opioid epidemic is a concern for all of us but especially for those struggling with extreme cancer-related pain.
The combination of Padcev plus Keytruda induced a high rate of durable objective response rates in patients with locally advanced or metastatic urothelial cancer.
A cancer survivor often contemplates which is the lesser of two evils – cancer or treatment?
Words of courage from a friend who knows that "getting through" may not be the point.
From thousands of patients with breast cancer told to be re-checked after a surgeon performed botched surgeries to three young brothers receiving the same eye cancer diagnosis, here’s what is making headlines in the cancer space this week.
Gratitude is my ultimate coping tool for managing my cancer survivorship.
Children with higher birth weight and body mass index, as well as taller height, are at a greater risk of developing renal cell carcinoma later in life, according to new study findings.
HPV and Anal cancer are associated with one another, here's what you need to know.
The LGBT community is faced with a disproportionate cancer burden that needs to be addressed.
Cancer, like many things in history, can be an unexpected landmark in our lives. With it can come crushing fear. If you feel that, even years after that moment in time, you are not alone.
The effects of the cancer journey extend to every member of the family, and children will often handle it differently than adults.
The Food and Drug Administration granted a priority review to KTE-X19 for the treatment of adult patients with relapsed or refractory mantle cell lymphoma.
The story of a Bamba, a Granddaddy, a parachute man and the anticipation to get through another procedure.
The Food and Drug Administration approved chemotherapy injection Pemfexy for the treatment of patients with nonsquamous non-small cell lung cancer.
February is National Cancer Prevention Month; do you know your risk of hereditary cancer?
An optimistic attitude can prove effective in battling a cancer diagnosis, no matter who you are.
As interest grows in the use of cannabinoids for the management of cancer-related pain, a recent study shows that they do not provide a benefit in pain management for patients with advanced cancer using opioids.
A cancer survivor laments not getting more done until she realizes she just moves slower, and that's ok. As long as you don't stop.
Although most older women with breast cancer didn’t use the painkillers persistently, new study findings show women who received chemotherapy were at greater risk of new-onset persistent use.
Why reducing your risk matters right now — whether you or someone you love is in treatment or hoping to avoid a recurrence.
From actress Shannen Doherty announcing she will continue to fight her stage 4 breast cancer to the Food and Drug Administration’s first hearing on asbestos testing in talc in 50 years, here’s what is making headlines in the cancer space this week.
The novel drug pairing of Venclexta and Gazyva, used for a fixed 12 months, is cost-effective compared with regimens that must be taken until disease progresses, a study finds.
Patients with stage 3 melanoma who had one or more circulating tumor cells were found to relapse sooner, providing physicians with an important biomarker to treat the likelihood of relapse.
Study findings showed that eradicating Helicobacter pylori infection reduced the risk of developing gastric cancer by 73% in those with a first-degree relative with the disease, compared with individuals in whom infection was persistent.
